NYSE: GLSGelesis Holdings Inc Stock
$0.33+0.03 (+10%)
Updated Feb 3, 2023
GLS Price
$0.33
Fair Value Price
N/A
Market Cap
$23.74M
52 Week Low
$0.20
52 Week High
$6.25
P/E
0.03x
P/B
-1.69x
P/S
3.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$26.03M
Earnings
-$51.66M
Gross Margin
39.6%
Operating Margin
-194.99%
Profit Margin
-172.2%
Debt to Equity
-8.79
Operating Cash Flow
-$90M
Beta
0.93
Next Earnings
Mar 22, 2023
Ex-Dividend
N/A
Next Dividend
N/A
GLS Overview
Capstar Special Purpose Acquisition Corp. intends on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was founded in 2020 and is based Austin, Texas.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GLS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GLS is good value based on its earnings relative to its share price (0.03x), compared to the US market average (15.09x)
P/E vs Market Valuation
GLS is good value based on its earnings relative to its share price (0.03x), compared to the US Biotechnology industry average (10.7x)
P/E vs Industry Valuation
GLS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more GLS due diligence checks available for Premium users.
Be the first to know about important GLS news, forecast changes, insider trades & much more!
GLS News
Valuation
GLS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.03x
Industry
10.7x
Market
15.09x
GLS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GLS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
GLS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.69x
Industry
5.11x
GLS's financial health
Profit margin
Revenue
$6.7M
Net Income
-$14.1M
Profit Margin
-213.9%
GLS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
GLS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$130.5M
Liabilities
$123.6M
Debt to equity
-8.79
GLS's short-term liabilities ($79.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GLS's short-term assets ($54.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GLS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GLS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$21.7M
Investing
-$3.4M
Financing
$24.8M
GLS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
GLS vs Biotech Stocks
Gelesis Holdings Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.